Lilly Falls on Oral Obesity Pill as FDA Decision Looms
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
An overview of where to locate stock index listings worldwide, with guidance on finding the right benchmarks for your analysis.
17,106 articlesEli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Centuri Holdings ends 2025 with a booming backlog and falling debt, yet investors face a high bar to justify lofty va...
Stocks moved higher after a choppy morning, with broad participation lifting the S&P 500 and SPY. Traders are weighin...
FuboTV has faced a brutal stretch, yet new synergies from Disney and Hulu may set up a rebound in EBITDA and subscrib...
ServiceNow's stock is down this year, but CEO Bill McDermott argues AI will accelerate growth, not derail it, outlini...
Get a clear, real-world view of Ligand (LGND) 2026 earnings. This guide breaks down revenue sources, milestones, and ...
As 2026 unfolds, Tesla and BYD are diverging on growth bets. This article weighs earnings, margins, and software stra...
Palantir has captured attention as a rapidly expanding AI software player. This guide breaks down the growth story, c...
Broadcom is edging toward a 52-week peak as AI demand fuels revenue growth and capital returns. Analysts weigh buy, h...
A practical, reader-friendly guide to interpreting Xunlei's Q1 2026 earnings. Learn what to watch, how to model resul...
IBM shares surged as a resurfaced media clip spotlighted the company’s leadership while federal backing for quantum r...
As offshore energy demand shifts, investors face a clear choice: TechnipFMC or Valaris. This guide breaks down how ea...